Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 8,673 | 8,283 | 9,396 | 9,206 | 9,334 |
| Operating Income | -8,673 | -8,283 | -9,396 | -9,206 | -9,334 |
| Interest Expense | 175 | 199 | 220 | 243 | 268 |
| Other Income | 70 | 63 | 171 | 31 | -4 |
| Pre-tax Income | -8,778 | -8,419 | -9,445 | -9,418 | -9,606 |
| Net Income Continuous | -8,778 | -8,419 | -9,445 | -9,418 | -9,606 |
| Net Income | $-8,778 | $-8,419 | $-9,445 | $-9,418 | $-9,606 |
| EPS Basic Total Ops | -27.59 | -32.39 | -36.59 | -36.59 | 1,061.79 |
| EPS Basic Continuous Ops | -27.03 | -32.56 | -36.85 | -36.84 | 1,062.14 |
| EPS Diluted Total Ops | -27.59 | -32.39 | -36.59 | -36.59 | 1,061.79 |
| EPS Diluted Continuous Ops | -27.03 | -32.56 | -36.85 | -36.84 | 1,062.14 |
| EBITDA(a) | $-8,578 | $-8,178 | $-9,293 | $-9,114 | $-9,262 |